Subscribe Now
Forgot Password?

Weekly News, Analysis, and Commentary

Large Joints Feature

Courtesy of ConforMIS

ConforMIS Awarded “3A” Rating in the UK

Biloine W. Young • Wed, March 7th, 2018

Print this article

ConforMIS, Inc., a medical technology company located in Billeric, Massachusetts, has been awarded a “3A” rating for its Total CR Knee replacement system.

The rating was given by the Orthopaedic Data Evaluation Panel (ODEP) in the United Kingdom reflecting on “strong evidence of implant performance over three years, including low revision rates as indicated in the United Kingdom’s National Joint Registry.”

“The positive ODEP 3A rating reaffirms my experience treating patients with the ConforMIS iTotal CR knee replacement system, which I believe offers my patients a more natural feeling knee with improved performance and mobility,” said Ian McDermott, FRCS, senior consultant knee surgeon at London Sports Orthopaedics, based at the London Bridge Hospital in London.

“The clinical evidence and three-year survivorship data together are consistent with the improvement I am seeing with my patients’ outcomes after knee replacement surgery using ConforMIS knee prostheses.”

“ODEP ratings provide a reliable, simple and independent assessment of the performance of an implant” said, Fahad G. Attar, MBChB, FRCS, Consultant Trauma & Orthopaedic Surgeon at BMI Alexandra and Whiston Hospital, St. Helens & Knowsley Teaching Hospitals, United Kingdom.

“I expect that this 3A rating will now provide additional reassurance and peace of mind to my patients and reinforce the performance reputation of ConforMIS iTotal CR knee replacement implants that contribute to the improved clinical outcomes I am seeing in my practice.”

Mark Augusti, company president and CEO said, “This rating provides another independent verification that our design philosophy, predicated on patient conforming implants, results in performance where it counts the most, in patients. We hope that this 3A rating also provides an opportunity for ConforMIS to expand its product offering to more patients receiving their healthcare in NHS [National Health Services] facilities.”

Send to a Friend

The article link will be sent to the email address you provide

Your Name (required)

Your Email (required)

Friend's Email (required)


Leave a Reply


Email Address (will not be published)